Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study
ConclusionThis study reveals that PF4-H Ab is a risk factor for developing CAD, IS, and AVFT among hemodialysis patients.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cardiology | Cardiovascular | Dialysis | Heart | Hemodialysis | Ischemic Stroke | Laboratory Medicine | Stroke | Study | Thrombocytopenia | Thrombosis | Urology & Nephrology